{
    "xml": "<topic id=\"PHP8546\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/nitrous-oxide\" basename=\"nitrous-oxide\" title=\"NITROUS OXIDE\">\n<title>NITROUS OXIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_52\" namespace=\"/interactions/list-of-drug-interactions/anaesthetics-general/nitrous-oxide\">Nitrous Oxide</xref>\n</p>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_670179538\" title=\"Anaesthetics (volatile liquid)\">Anaesthetics (volatile liquid)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP34822\" outputclass=\"indicationsAndDose\" rev=\"1.18\" parent=\"/drugs/nitrous-oxide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Maintenance of anaesthesia in conjunction with other anaesthetic agents</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8211;66&#8239;%, to be administered using suitable anaesthetic apparatus in oxygen.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Analgesia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Up to 50&#8239;%, to be administered using suitable anaesthetic apparatus in oxygen, adjusted according to the patient's needs.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34871\" outputclass=\"importantSafetyInformation\" rev=\"1.10\" parent=\"/drugs/nitrous-oxide\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Nitrous oxide should only be administered by, or under the direct supervision of, personnel experienced in its use, with adequate training in anaesthesia and airway management, and when resuscitation equipment is available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34880\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/nitrous-oxide\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Entrapped air following recent underwater dive</ph>; <ph outputclass=\"caution\">pneumothorax</ph>; <ph outputclass=\"caution\">presence of intracranial air after head injury</ph>; <ph outputclass=\"caution\">recent intra-ocular gas injection</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p>Nitrous oxide may have a deleterious effect if used in patients with an air-containing closed space since nitrous oxide diffuses into such a space with a resulting increase in pressure. This effect may be dangerous in conditions such as pneumothorax, which may enlarge to compromise respiration, or in the presence of intracranial air after head injury, entrapped air following recent underwater dive, or recent intra-ocular gas injection.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34807\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/nitrous-oxide\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (anaesthetics, general).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34731\" outputclass=\"sideEffects\" rev=\"1.16\" parent=\"/drugs/nitrous-oxide\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Depression of white cell formation</ph>; <ph outputclass=\"sideEffect\">hypoxia</ph>; <ph outputclass=\"sideEffect\">megaloblastic anaemia</ph>; <ph outputclass=\"sideEffect\">neurological toxic effects</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Hypoxia</p>\n<p>Hypoxia can occur immediately following the administration of nitrous oxide; additional oxygen should always be given for several minutes after stopping the flow of nitrous oxide.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Prolonged exposure</p>\n<p>Exposure of patients to nitrous oxide for prolonged periods, either by continuous or by intermittent administration, may result in megaloblastic anaemia owing to interference with the action of vitamin B<sub>12</sub>; neurological toxic effects can occur without preceding overt haematological changes. Depression of white cell formation may also occur.</p>\n<p>Nitrous oxide should <b>not</b> be given continuously for longer than 24 hours or more frequently than every 4 days without close supervision and haematological monitoring.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34792\" outputclass=\"pregnancy\" parent=\"/drugs/nitrous-oxide\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>May depress neonatal respiration if used during delivery.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34883\" outputclass=\"breastFeeding\" parent=\"/drugs/nitrous-oxide\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Breast-feeding can be resumed as soon as mother has recovered sufficiently from anaesthesia.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34663\" outputclass=\"monitoringRequirements\" parent=\"/drugs/nitrous-oxide\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Assessment of plasma-vitamin B<sub>12</sub> concentration should be considered in those at risk of deficiency, including the elderly, those who have a poor, vegetarian, or vegan diet, and those with a history of anaemia.</p>\n<p>Nitrous oxide should <b>not</b> be given continuously for longer than 24 hours or more frequently than every 4 days without close supervision and haematological monitoring.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34889\" outputclass=\"directionsForAdministration\" rev=\"1.17\" parent=\"/drugs/nitrous-oxide\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>For analgesia (without loss of consciousness), a mixture of nitrous oxide and oxygen containing 50% of each gas (Entonox<tm tmtype=\"reg\"/>, Equanox<tm tmtype=\"reg\"/>) is used.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34854\" outputclass=\"handlingAndStorage\" rev=\"1.10\" parent=\"/drugs/nitrous-oxide\">\n<title>Handling and storage</title>\n<body>\n<section>\n<sectiondiv>\n<p>Exposure of theatre staff to nitrous oxide should be minimised (risk of serious side-effects).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP8546-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/nitrous-oxide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP94216\" title=\"Inhalation gas\" namespace=\"/drugs/nitrous-oxide/inhalation-gas\">Inhalation gas</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78539\" namespace=\"/treatment-summaries/general-anaesthesia\" title=\"General anaesthesia\" count=\"6\" rel=\"backlink\">General anaesthesia</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_52\" namespace=\"/interactions/list-of-drug-interactions/anaesthetics-general/nitrous-oxide\" title=\"Nitrous Oxide\" count=\"1\" rel=\"link\">Nitrous Oxide</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP94216\" namespace=\"/drugs/nitrous-oxide/inhalation-gas\" title=\"Inhalation gas\" count=\"1\" rel=\"link\">Inhalation gas</xref>\n</links>\n</topic>",
    "id": "PHP8546",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/nitrous-oxide",
    "basename": "nitrous-oxide",
    "title": "NITROUS OXIDE",
    "interactants": [
        {
            "id": "bnf_int_52",
            "label": "Nitrous Oxide"
        }
    ],
    "drugClassification": [
        "Anaesthetics (volatile liquid)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Maintenance of anaesthesia in conjunction with other anaesthetic agents",
                        "html": "Maintenance of anaesthesia in conjunction with other anaesthetic agents"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation"
                    ],
                    "textContent": "By inhalation",
                    "html": "By inhalation"
                },
                "adult": [
                    {
                        "textContent": "50&#8211;66 %, to be administered using suitable anaesthetic apparatus in oxygen.",
                        "html": "<p>50&#8211;66&#8239;%, to be administered using suitable anaesthetic apparatus in oxygen.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Analgesia",
                        "html": "Analgesia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation"
                    ],
                    "textContent": "By inhalation",
                    "html": "By inhalation"
                },
                "adult": [
                    {
                        "textContent": "Up to 50 %, to be administered using suitable anaesthetic apparatus in oxygen, adjusted according to the patient's needs.",
                        "html": "<p>Up to 50&#8239;%, to be administered using suitable anaesthetic apparatus in oxygen, adjusted according to the patient's needs.</p>"
                    }
                ]
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "textContent": "Nitrous oxide should only be administered by, or under the direct supervision of, personnel experienced in its use, with adequate training in anaesthesia and airway management, and when resuscitation equipment is available.",
                "html": "<p>Nitrous oxide should only be administered by, or under the direct supervision of, personnel experienced in its use, with adequate training in anaesthesia and airway management, and when resuscitation equipment is available.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Entrapped air following recent underwater dive",
                "html": "Entrapped air following recent underwater dive"
            },
            {
                "type": "cautions",
                "textContent": "pneumothorax",
                "html": "pneumothorax"
            },
            {
                "type": "cautions",
                "textContent": "presence of intracranial air after head injury",
                "html": "presence of intracranial air after head injury"
            },
            {
                "type": "cautions",
                "textContent": "recent intra-ocular gas injection",
                "html": "recent intra-ocular gas injection"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "textContent": "Nitrous oxide may have a deleterious effect if used in patients with an air-containing closed space since nitrous oxide diffuses into such a space with a resulting increase in pressure. This effect may be dangerous in conditions such as pneumothorax, which may enlarge to compromise respiration, or in the presence of intracranial air after head injury, entrapped air following recent underwater dive, or recent intra-ocular gas injection.",
                "html": "<p>Nitrous oxide may have a deleterious effect if used in patients with an air-containing closed space since nitrous oxide diffuses into such a space with a resulting increase in pressure. This effect may be dangerous in conditions such as pneumothorax, which may enlarge to compromise respiration, or in the presence of intracranial air after head injury, entrapped air following recent underwater dive, or recent intra-ocular gas injection.</p>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (anaesthetics, general).",
                "html": "<p>Appendix 1 (anaesthetics, general).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Depression of white cell formation",
                        "html": "Depression of white cell formation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypoxia",
                        "html": "hypoxia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "megaloblastic anaemia",
                        "html": "megaloblastic anaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "neurological toxic effects",
                        "html": "neurological toxic effects",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Hypoxia",
                "textContent": "Hypoxia can occur immediately following the administration of nitrous oxide; additional oxygen should always be given for several minutes after stopping the flow of nitrous oxide.",
                "html": "<p>Hypoxia can occur immediately following the administration of nitrous oxide; additional oxygen should always be given for several minutes after stopping the flow of nitrous oxide.</p>"
            },
            {
                "type": "advice",
                "title": "Prolonged exposure",
                "textContent": "Exposure of patients to nitrous oxide for prolonged periods, either by continuous or by intermittent administration, may result in megaloblastic anaemia owing to interference with the action of vitamin B12; neurological toxic effects can occur without preceding overt haematological changes. Depression of white cell formation may also occur.\n\nNitrous oxide should not be given continuously for longer than 24 hours or more frequently than every 4 days without close supervision and haematological monitoring.",
                "html": "<p>Exposure of patients to nitrous oxide for prolonged periods, either by continuous or by intermittent administration, may result in megaloblastic anaemia owing to interference with the action of vitamin B<sub>12</sub>; neurological toxic effects can occur without preceding overt haematological changes. Depression of white cell formation may also occur.</p><p>Nitrous oxide should <b>not</b> be given continuously for longer than 24 hours or more frequently than every 4 days without close supervision and haematological monitoring.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "May depress neonatal respiration if used during delivery.",
                "html": "<p>May depress neonatal respiration if used during delivery.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Breast-feeding can be resumed as soon as mother has recovered sufficiently from anaesthesia.",
                "html": "<p>Breast-feeding can be resumed as soon as mother has recovered sufficiently from anaesthesia.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Assessment of plasma-vitamin B12 concentration should be considered in those at risk of deficiency, including the elderly, those who have a poor, vegetarian, or vegan diet, and those with a history of anaemia.\n\nNitrous oxide should not be given continuously for longer than 24 hours or more frequently than every 4 days without close supervision and haematological monitoring.",
                "html": "<p>Assessment of plasma-vitamin B<sub>12</sub> concentration should be considered in those at risk of deficiency, including the elderly, those who have a poor, vegetarian, or vegan diet, and those with a history of anaemia.</p><p>Nitrous oxide should <b>not</b> be given continuously for longer than 24 hours or more frequently than every 4 days without close supervision and haematological monitoring.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "For analgesia (without loss of consciousness), a mixture of nitrous oxide and oxygen containing 50% of each gas (Entonox, Equanox) is used.",
                "html": "<p>For analgesia (without loss of consciousness), a mixture of nitrous oxide and oxygen containing 50% of each gas (Entonox<tm tmtype=\"reg\"/>, Equanox<tm tmtype=\"reg\"/>) is used.</p>"
            }
        ]
    },
    "handlingAndStorage": {
        "handlingAndStorage": [
            {
                "type": "handlingAndStorage",
                "textContent": "Exposure of theatre staff to nitrous oxide should be minimised (risk of serious side-effects).",
                "html": "<p>Exposure of theatre staff to nitrous oxide should be minimised (risk of serious side-effects).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP94216",
                "label": "Inhalation gas",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78539",
                "label": "General anaesthesia",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_52",
                "label": "Nitrous Oxide",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP94216",
                "label": "Inhalation gas",
                "type": "medicinalForm"
            }
        ]
    }
}